Health Canada - Federal department responsible for drug approvals and health regulation in Canada
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| AZITHROMYCIN FOR INJECTION | generic medical partners inc | Marketed | Mar 1, 2023 | Marketed |
| BYOOVIZ | Samsung Bioepis Co., Ltd. | Marketed | Mar 1, 2023 | Marketed |
| QULIPTA | Abbvie Corporation | Marketed | Mar 1, 2023 | Marketed |
| JAMP TOPIRAMATE TABLETS | Jamp Pharma Corporation | Marketed | Mar 1, 2023 | Marketed |
| NAT-POMALIDOMIDE | natco pharma (canada) inc | Marketed | Feb 28, 2023 | Marketed |
| SANDOZ POMALIDOMIDE | Sandoz Canada, Inc. | Marketed | Feb 28, 2023 | Marketed |
| APO-POMALIDOMIDE | Apotex Inc | Marketed | Feb 28, 2023 | Marketed |
| NAT-POMALIDOMIDE | natco pharma (canada) inc | Marketed | Feb 28, 2023 | Marketed |
| APO-POMALIDOMIDE | Apotex Inc | Marketed | Feb 28, 2023 | Marketed |
| NAT-POMALIDOMIDE | natco pharma (canada) inc | Marketed | Feb 28, 2023 | Marketed |
| APO-POMALIDOMIDE | Apotex Inc | Marketed | Feb 28, 2023 | Marketed |
| NAT-POMALIDOMIDE | natco pharma (canada) inc | Marketed | Feb 28, 2023 | Marketed |
| SANDOZ POMALIDOMIDE | Sandoz Canada, Inc. | Marketed | Feb 28, 2023 | Marketed |
| APO-POMALIDOMIDE | Apotex Inc | Marketed | Feb 28, 2023 | Marketed |
| SANDOZ POMALIDOMIDE | Sandoz Canada, Inc. | Marketed | Feb 28, 2023 | Marketed |
| SANDOZ POMALIDOMIDE | Sandoz Canada, Inc. | Marketed | Feb 28, 2023 | Marketed |
| MOXICLOPRID 9 | MODERN VETERINARY THERAPEUTICS LLC | Marketed | Feb 27, 2023 | Marketed |
| MOXICLOPRID 20 | MODERN VETERINARY THERAPEUTICS LLC | Marketed | Feb 27, 2023 | Marketed |
| MOXICLOPRID 100 | MODERN VETERINARY THERAPEUTICS LLC | Marketed | Feb 27, 2023 | Marketed |
| MOXICLOPRID 10 | MODERN VETERINARY THERAPEUTICS LLC | Marketed | Feb 27, 2023 | Marketed |
